Did the FDA understaff its review of the Pfizer/BioNTech vaccine?

Doshi, PeterHerder, Matthew2021-12-162021-12-162020-12-17http://hdl.handle.net/10713/17419enEmergency Use AuthorizationFDA reviewersUnited States. Food and Drug AdministrationBNT 162 VaccineCOVID-19 VaccinesDid the FDA understaff its review of the Pfizer/BioNTech vaccine?Article